Is Alzheimer's disease, relentless and slow, a better target for clinical trials?

Published Date: 16 Feb 2023

According to a report by the Alzheimer's Association task force, it's time to reframe what "clinically meaningful" means and change expectations about clinical trials.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New BCMA-Directed Therapies Show Promise in Multiple Myeloma

2.

FDA Approves Subcutaneous Isatuximab for MM Indications

3.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

4.

Can a Betting Market Offer Hope to a Cancer Patient?

5.

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot